<p>Sophia Genetics SA announced that Ross Muken will become Chief Executive Officer effective July 1, 2026, succeeding co-founder Dr. Jurgi Camblong, who will transition to Executive Chairman of the Board, pending election at the company’s Annual General Meeting in June 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-26-000354), on January 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

SOPH

<p>Sophia Genetics SA has appointed Ross Muken as the new CEO, effective July 1, 2026, succeeding co-founder Dr. Jurgi Camblong, who will become Executive Chairman of the Board after the Annual General Meeting in June 2026.</p>

Sophia Genetics Names Ross Muken CEO as Jurgi Camblong Becomes Executive Chairman